Advertisement

Topics

Latest Biotechnology NewsRSS

12:39 EST 23rd January 2019 | BioPortfolio

genomics, robotics, sample preparation, biotechnology, automated dilution, HTS

Provider,of,symposiums,for,bioinformatics,genomics,robotics,pharmacology,toxicology

The biotechnology company Celgene, sold for $74 billion, leaves behind a legacy of chutzpah both in science and in how it priced its drugs. https://buff.ly/2FR77aH 

The biotechnology company Celgene, sold for $74 billion, leaves behind a legacy of chutzpah both in science and in how it priced its drugs. https://buff.ly/2FR77aH 

Will AVRO Reverse Course In Run-up To February Event?

Shares of AVROBIO Inc. (AVRO) have lost 39% of their value over the last 1 month in sharp contrast to the iShares Nasdaq Biotechnology ETF (IBB) index which has gained 8% during the same period.

Generex Biotechnology Provides 2018 Year-End Summary & 2019 Plans

Acquisitions, Financing, Expansion Initiatives & Strategic Plans MIRAMAR, FL, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is happy to provide the investment community with a revi

#news #biotech DNA’s on/off switch

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: DNA’s on/off switch .The enzyme DNA primase synthesizes the RNA primers essential to initiate the replication of our genomes. from Biotechnology News – Biology News http://bit.ly/2RGU1Uk

#news #biotech AMR: Novo Holdings funds companies with €18m

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AMR: Novo Holdings funds companies with €18m . from European Biotechnology – first and foremost in European biotech http://bit.ly/2AUNPOi

Pittcon

March 17-21, 2019 Philadelphia, PA www.pittcon.org The post Pittcon appeared first on GEN - Genetic Engineering and Biotechnology News.

#news #biotech Boehringer expands neurology activities

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Boehringer expands neurology activities . from European Biotechnology – first and foremost in European biotech http://bit.ly/2U1fZOT

Adaptive Biotechnologies Announces Medicare Coverage of the clonoSEQ® Assay for MRD Testing in Patients with Multiple Myeloma and Acute Lymphoblastic Leukemia at Multiple Timepoints Throughout Treatment and Remission

Adaptive Biotechnologies, an immune driven-medicine company, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) and leader in assessing diagnostic technologies through its MolDX program, has established coverage of the clonoSEQ® Assay for Medicare patients with multiple myeloma and B-cell acute lymphoblastic leukemia (ALL). clon...

#news #biotech New target for lung fibrosis discovered

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New target for lung fibrosis discovered . from European Biotechnology – first and foremost in European biotech http://bit.ly/2TYysvt

#news #biotech Target for lung fibrosis discovered

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Target for lung fibrosis discovered . from European Biotechnology – first and foremost in European biotech http://bit.ly/2DdAjqr

Kathy Liszewski and @GENbio Genetic Engineering & Biotechnology News just published an excelent article featuring #zebrafish in #targetID and #validation plus @ZeClinics' own #CRISPR expert Vincenzo Di Donato. Don't you miss it! https://bit.ly/2QSrQNd p

Kathy Liszewski and @GENbio Genetic Engineering & Biotechnology News just published an excelent article featuring #zebrafish in #targetID and #validation plus @ZeClinics' own

#news #biotech Valneva inks $59m JE vaccine supply contract

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Valneva inks $59m JE vaccine supply contract . from European Biotechnology – first and foremost in European biotech http://bit.ly/2DemVCB

The Coming of Age of Biotechnology

Since its beginnings in the 1970s, the biotech industry has grown massively and made huge advances. At our recent Labiotech Refresh in London, Tim Haines, Managing Partner at the life science VC Abingworth, shared his views on how biotechnology has ... The post The Coming of Age of Biotechnology appeared first on Labiotech.eu.

AroCell signs distribution agreement with Gongyingshi in China for AroCell TK 210 ELISA

AroCell AB (publ) announced today that a distribution agreement has been signed with the Beijing based company Gongyingshi for the promotion and distribution of the AroCell TK 210™ ELISA in China. The pharmaceutical and biotechnological industries are growing rapidly in … Continue reading →

#news #biotech VTT turn waste into biofuels and chemicals

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: VTT turn waste into biofuels and chemicals . from European Biotechnology – first and foremost in European biotech http://bit.ly/2TPyzJo

AXIM® Biotechnologies Launches New Website and Management Presentation To Outline Strategic Business Initiatives

NEW YORK, Jan. 15, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the launch of a new corporate website and release of i

Orion Biotechnology Reports Positive Results for Colorectal Cancer in Preclinical Study

OTTAWA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data produced in collaboration with Charles River Laboratories, evaluating the efficacy of OB-002O (5P12-RANTES) in colorectal cancer. BALB/c mice were inoculated subcutaneously with the CT-26 colorectal cancer cell line. Three days after inoculation in...

UNITY Biotechnologies Selects a New Senolytic Candidate

Another senolytic drug candidate has entered development at

Innoviva's On A Roll.

Shares of Innoviva Inc. (INVA), which recently touched a new 52-week high of $19.82, are up 12% so far this month, slightly lagging behind the iShares NASDAQ Biotechnology Index (ETF) (IBB), which has gained 14% during the same period.

#news #biotech Tissue specific tumour transition needs few cells

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Tissue specific tumour transition needs few cells . from European Biotechnology – first and foremost in European biotech http://bit.ly/2FyhkZA

Blockchain to Secure a More Personalized Pharma

Though the cryptocurrency side of blockchain technology has dominated news headlines in the last year, the technology has real promise in biotechnology and the life sciences. A recent survey (September 2018) by the Pistoia Alliance found that 60% of professionals in the pharmaceutical and life sciences industries were using or experimenting with blockchain technologies in […] The post Blockc...

#news #biotech Drug dissociates metastasis precursors in blood

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Drug dissociates metastasis precursors in blood . from European Biotechnology – first and foremost in European biotech http://bit.ly/2SNWk4N

#news #biotech Policymakers take no action after ECJ mutagenesis ruling

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Policymakers take no action after ECJ mutagenesis ruling . from European Biotechnology – first and foremost in European biotech http://bit.ly/2siaz67

Asymmetrex Publishes Chapter Explaining the Critical Need for Stem Cell Dosing for Success in Stem Cell Medicine

Since September 2018, Massachusetts stem cell biotechnology company Asymmetrex has been pursuing a campaign to increase awareness of the adult tissue stem cell counting problem in stem cell medicine and the stem cell supply industry. The latest 2018 installment in this effort is a book chapter, authored by Asymmetrex’s founder and director, that illuminates why a means to count the number of ste...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Biotechnology market research data and corporate reports here